Results 1 to 10 of about 543,215 (120)
Medical prognostic (prediction) models (MPM) are essential in modern healthcare. They determine health and disease risks and are created to improve diagnosis and treatment outcomes. All MPMs fall into two categories.
Aleksander Sergeevich Luchinin
doaj +1 more source
A Prognostic Model for Breast Cancer With Liver Metastasis
Background: Breast cancer with liver metastasis consists of a group of heterogeneous diseases, and survival time may be significantly different, ranging from a few months to several years.
Lei Ji +10 more
doaj +1 more source
Pyroptosis has profound impacts on tumor cell proliferation, invasion, and metastasis and is of great clinical significance for different cancers. However, the role of pyroptosis in the progression and prognosis of muscle invasive bladder cancer (MIBC ...
Qi Zhang +15 more
doaj +1 more source
Background: Triple-negative breast cancer (TNBC) is a special subtype of breast cancer with poor prognosis. DNA damage response (DDR) is one of the hallmarks of this cancer.
Nan Wang +8 more
doaj +1 more source
The incidence of head and neck squamous cell carcinoma (HNSC) is increasing year by year. The nerve is an important component of the tumor microenvironment, which has a wide range of cross-talk with tumor cells and immune cells, especially in highly ...
Jun Li +6 more
doaj +1 more source
Background: The study focused on establishing a prognostic survival model with six necroptosis-related lncRNAs to predict overall survival (OS) in patients with hepatocellular carcinoma (HCC).Methods: The data of gene expression and clinical information ...
Min Chen +6 more
doaj +1 more source
BackgroundAs a tumor type with high mortality and poor therapeutic effect, the pathogenesis of pancreatic cancer is still unclear. It is necessary to explore the significance of necroptosis in pancreatic cancer.MethodsPancreatic cancer transcriptome data
Liang Chen +8 more
doaj +1 more source
BackgroundThe prognosis of diffuse low-grade gliomas (DLGGs, WHO grade 2) is highly variable, making it difficult to evaluate individual patient outcomes.
Lei Ao +10 more
doaj +1 more source
A signature-based classification of lung adenocarcinoma that stratifies tumor immunity
BackgroundImmune-related subgroup classification in immune checkpoint blockade (ICB) therapy is largely inconclusive in lung adenocarcinoma (LUAD).Materials and methodsFirst, the single-sample Gene Set Enrichment Analysis (ssGSEA) and K-means algorithms ...
Xun Zhang +5 more
doaj +1 more source
Background: Diffuse large B-cell lymphoma (DLBCL) is the most common type of lymphoma which that highly aggressive and heterogeneous. Glycolysis has been implicated in the regulation of tumor microenvironment (TME) and development.
Yingying Cui +4 more
doaj +1 more source

